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N
anotechnology can be 
harnessed to address some 
of the world’s most critical 
development problems. However, to 
our knowledge, there has been no 
systematic prioritization of applications 
of nanotechnology targeted toward 
these challenges faced by the 5 billion 
people living in the developing world. 
In this article, we aim to convey 
three key messages. First, we show 
that developing countries are already 
harnessing nanotechnology to address 
some of their most pressing needs. 
Second, we identify and rank the 
ten applications of nanotechnology 
most likely to beneﬁ  t developing 
countries, and demonstrate that 
these applications can contribute 
to the attainment of the United 
Nations Millennium Development 
Goals (MDGs). Third, we propose a 
way for the international community 
to accelerate the use of these top 
nanotechnologies by less industrialized 
countries to meet critical sustainable 
development challenges.
Developing Countries Innovate 
in Nanotechnology
Several developing countries have 
launched nanotechnology initiatives 
in order to strengthen their capacity 
and sustain economic growth [1]. 
India’s Department of Science and 
Technology will invest $20 million 
over the next ﬁ  ve years (2004–2009) 
for their Nanomaterials Science and 
Technology Initiative [2]. Panacea 
Biotec (http:⁄⁄www.panacea-biotec.
com/products/products.htm) (New 
Delhi, India) is conducting novel drug 
delivery research using mucoadhesive 
nanoparticles, and Dabur Research 
Foundation (Ghaziabad, India) 
is participating in Phase-1 clinical 
trials of nanoparticle delivery of the 
anti-cancer drug paclitaxel [3]. The 
number of nanotechnology patent 
applications from China ranks third 
in the world behind the United States 
and Japan [4]. In Brazil, the projected 
budget for nanoscience during the 
2004–2007 period is about $25 million, 
and three institutes, four networks, 
and approximately 300 scientists 
are working in nanotechnology [5]. 
The South African Nanotechnology 
Initiative (http:⁄⁄www.sani.org.za) 
is a national network of academic 
researchers involved in areas such as 
nanophase catalysts, nanoﬁ  ltration, 
nanowires, nanotubes, and quantum 
dots (Figure 1). Other developing 
countries, such as Thailand, the 
Philippines, Chile, Argentina, 
and Mexico, are also pursuing 
nanotechnology [1].
Science and technology alone are not 
the answer to sustainable development 
challenges. Like any other science 
and technology waves, nanoscience 
and nanotechnology are not “silver 
bullets” that will magically solve all the 
problems of developing countries; the 
social context of these countries must 
always be considered. Nevertheless, 
science and technology are a critical 
component of development [6]. The 
2001 Human Development Report 
[7] of the UN Development Program 
clearly illustrates the important 
roles of science and technology 
in reducing mortality rates and 
improving life expectancy in the period 
1960–1990, but it did not emphasize 
nanotechnology speciﬁ  cally. In a report 
released in early 2005 [8], the UN 
Task Force on Science, Technology 
and Innovation (part of the process 
designed to assist UN agencies in 
achieving the UN MDGs) addresses 
the potential of nanotechnology for 
sustainable development. 
Top Ten Nanotechnologies 
Contributing to the MDGs 
In order to provide a systematic 
approach with which to address 
sustainable development issues in the 
developing world, we have identiﬁ  ed 
and ranked the ten applications of 
nanotechnology most likely to beneﬁ  t 
developing countries. We used a 
modiﬁ  ed Delphi Method, as described 
in our Top Ten Biotechnologies 
report [9] to identify and prioritize the 
applications and to achieve consensus 
among the panelists.
We recruited an international panel 
of 85 experts in nanotechnology who 
could provide the informed judgments 
that this study required, of which 63 
completed the project (Table S1). 
We selected the panelists based on 
contacts identiﬁ  ed in our previous 
study on nanotechnology in developing 
countries [1]. A conscious effort was 
made to balance the panel with respect 
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A Deﬁ  nition of Nanotechnology
Nanotechnology is the study, design, 
creation, synthesis, manipulation, and 
application of functional materials, 
devices, and systems through control of 
matter at the nanometer scale (1–100 
nanometers, one nanometer being 
equal to 1 × 10−9 of a meter), that is, at 
the atomic and molecular levels, and the 
exploitation of novel phenomena and 
properties of matter at that scale.
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to gender, specialty areas within 
nanotechnology, and geographic 
distribution. Of the panelists, 38 (60%) 
were from developing countries and 
25 (40%) from developed countries; 
51 panelists (81%) were male and 12 
(19%) were female.
We posed the following open-ended 
question: “Which do you think are the 
nanotechnologies most likely to beneﬁ  t 
developing countries in the areas of 
water, agriculture, nutrition, health, 
energy, and the environment in the next 
10 years?” These areas were identiﬁ  ed 
in the 2002 UN Johannesburg Summit 
on Sustainable Development [10]. 
We asked the panelists to answer this 
question using the following criteria 
derived from our previous Top Ten 
Biotechnologies study. 
Impact. How much difference will 
the technology make in improving 
water, agriculture, nutrition, health, 
energy, and the environment in 
developing countries?
Burden. Will it address the most 
pressing needs?
Appropriateness. Will it be 
affordable, robust, and adjustable 
to settings in developing countries, 
and will it be socially, culturally, and 
politically acceptable?
Feasibility. Can it realistically be 
developed and deployed in a time 
frame of ten years?
Knowledge gap. Does the technology 
advance quality of life by creating new 
knowledge?
Indirect beneﬁ  ts. Does it address 
issues such as capacity building and 
income generation that 
have indirect, positive 
effects on developing 
countries?
Three Delphi rounds 
were conducted using 
e-mail messages, faxes, 
and phone calls. In the 
ﬁ  rst round, the panelists 
proposed examples of 
nanotechnologies in 
response to our study 
question. We analyzed 
and organized their 
answers according 
to common themes 
and generated a list 
of twenty distinct 
nanotechnology 
applications. This list 
was reviewed for face 
and content validity 
by two nanotechnologists external 
to the panel. In the second Delphi 
round, the panelists ranked their top 
ten choices from the 20 applications 
provided and gave reasons for their 
choices. To analyze the data, we 
produced a summative point score for 
each application, ranked the list, and 
summarized the panelists’ reasons. 
Then we redistributed the top 13 
applications, instead of the top ten, to 
generate a greater number of choices 
for increased accuracy in the last 
round. Thus, the highest score possible 
for an application was 819 (63 × 13). 
The ﬁ  nal Delphi round was devoted to 
consolidating consensus by re-ranking 
the top ten of the 13 choices obtained 
in the previous round and to gathering 
concrete examples of each application 
from the panelists.
Our results, shown in Table 1, 
were compiled from January to July 
2004. They display a high degree of 
consensus with regard to the top four 
applications: all of the panelists cited at 
least one of the top four applications in 
their personal top four rankings, with 
the majority citing at least three. 
To further assess the impact of 
nanotechnology on sustainable 
development, we have compared 
the top ten applications with the UN 
Millennium Development Goals (Table 
1 and Figure 2). The MDGs are eight 
goals that aim to promote human 
development and encourage social 
and economic sustainability [11]. In 
2000, all 189 member states of the 
UN committed to achieve the MDGs 
by 2015. The MDGs are: (i) Eradicate 
extreme poverty and hunger; (ii) 
Achieve universal primary education; 
(iii) Promote gender equality and 
empower women; (iv) Reduce child 
mortality; (v) Improve maternal health; 
(vi) Combat HIV/AIDS, malaria, 
and other diseases; (vii) Ensure 
environmental sustainability; and 
(viii) Develop a global partnership for 
development. As shown in Table 1 and 
Figure 2, the top ten nanotechnology 
applications can contribute to 
achieving the UN MDGs.
Addressing Global Challenges 
Using Nanotechnology
What can the international 
community do to support the 
application of nanotechnology in 
developing countries? In 2002, the 
National Institutes of Health (NIH) 
conceptualized a roadmap for medical 
research to identify major opportunities 
and gaps in biomedical investigations. 
Nanomedicine is one of the areas of 
implementation that has been outlined 
to address this concern. Several of the 
applications of nanotechnology that 
we have identiﬁ  ed in our study can aid 
the NIH in this process by targeting 
the areas of research that need to be 
addressed in order to combat some of 
the serious medical issues facing the 
developing world. 
To expand on this idea, we propose 
an initiative, called “Addressing Global 
Challenges Using Nanotechnology,” to 
accelerate the use of nanotechnology 
to address critical sustainable 
development challenges. We model 
this proposal on the Foundation for 
the NIH/Bill and Melinda Gates 
Foundation’s Grand Challenges in 
Global Health [12], which itself was 
based on Hilbert’s Grand Challenges in 
Mathematics. 
A grand challenge is meant to direct 
investigators to seek a speciﬁ  c scientiﬁ  c 
or technological breakthrough 
that would overcome one or more 
bottlenecks in an imagined path to 
solving a signiﬁ  cant development 
problem (or preferably, several) 
[12]. A scientiﬁ  c board similar 
to the one created for the Grand 
Challenges in Global Health, with 
strong representation of developing 
countries, will need to be established 
to provide guidance and oversee the 
program. The top ten nanotechnology 
applications identiﬁ  ed in Table 1 are 
DOI: 10.1371/journal.pmed.0020097.g001
Figure 1. Quantum Dots for Disease Diagnostics
Quantum dots may be used for cheap, efﬁ  cient handheld 
diagnostic devices available at point-of-care institutions in 
developing countries.
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a good starting point for deﬁ  ning the 
grand challenges. 
The funding to address global 
challenges using nanotechnology 
could come from various sources, 
including national and international 
foundations, and from collaboration 
among nanotechnology initiatives 
in industrialized and developing 
countries. These funds could be 
signiﬁ  cantly increased if industrialized 
nations adopted the target set in 
February 2004 by Paul Martin, Prime 
Minister of Canada: that 5% of 
Canada’s research and development 
investment be used to address 
developing world challenges [13]. 
In parallel to the allocation of public 
funds, policies should provide 
incentives for the private sector to 
direct a portion of their research 
and development toward funding 
our initiative. The UN Commission 
on Private Sector and Development 









1 (766)a Energy storage, 
production, and 
conversion 
Novel hydrogen storage systems based on carbon nanotubes and other 
lightweight nanomaterials
Photovoltaic cells and organic light-emitting devices based on quantum 
dots
Carbon nanotubes in composite ﬁ  lm coatings for solar cells
Nanocatalysts for hydrogen generation
Hybrid protein-polymer biomimetic membranes
VII
2 (706) Agricultural 
productivity 
enhancement 
Nanoporous zeolites for slow-release and efﬁ  cient dosage of water and 
fertilizers for plants, and of nutrients and drugs for livestock
Nanocapsules for herbicide delivery
Nanosensors for soil quality and for plant health monitoring
Nanomagnets for removal of soil contaminants
I, IV, V, VII
3 (682) Water treatment and 
remediation 
Nanomembranes for water puriﬁ  cation, desalination, and detoxiﬁ  cation
Nanosensors for the detection of contaminants and pathogens
Nanoporous zeolites, nanoporous polymers, and attapulgite clays for 
water puriﬁ  cation
Magnetic nanoparticles for water treatment and remediation
TiO2 nanoparticles for the catalytic degradation of water pollutants
I, IV, V, VII
4 (606) Disease diagnosis 
and screening 
Nanoliter systems (Lab-on-a-chip) 
Nanosensor arrays based on carbon nanotubes
Quantum dots for disease diagnosis
Magnetic nanoparticles as nanosensors
Antibody-dendrimer conjugates for diagnosis of HIV-1 and cancer
Nanowire and nanobelt nanosensors for disease diagnosis
Nanoparticles as medical image enhancers
IV, V, VI
5 (558) Drug delivery 
systems 
Nanocapsules, liposomes, dendrimers, buckyballs, nanobiomagnets, 
and attapulgite clays for slow and sustained drug release systems
IV, V, VI
6 (472) Food processing and 
storage 
Nanocomposites for plastic ﬁ  lm coatings used in food packaging 
Antimicrobial nanoemulsions for applications in decontamination of 
food equipment, packaging, or food
Nanotechnology-based antigen detecting biosensors for identiﬁ  cation 
of pathogen contamination
I, IV, V
7 (410) Air pollution and 
remediation 
TiO2 nanoparticle-based photocatalytic degradation of air pollutants in 
self-cleaning systems
Nanocatalysts for more efﬁ  cient, cheaper, and better-controlled 
catalytic converters
Nanosensors for detection of toxic materials and leaks
Gas separation nanodevices
IV, V, VII
8 (366) Construction Nanomolecular structures to make asphalt and concrete more robust to 
water seepage
Heat-resistant nanomaterials to block ultraviolet and infrared radiation 
Nanomaterials for cheaper and durable housing, surfaces, coatings, 
glues, concrete, and heat and light exclusion
Self-cleaning surfaces (e.g., windows, mirrors, toilets) with bioactive 
coatings
VII
9 (321) Health monitoring  Nanotubes and nanoparticles for glucose, CO2, and cholesterol sensors 
and for in-situ monitoring of homeostasis
IV, V, VI
10 (258) Vector and pest 
detection and 
control 
Nanosensors for pest detection
Nanoparticles for new pesticides, insecticides, and insect repellents
IV, V, VI
a The maximum total score an application could receive was 819.
DOI: 10.1371/journal.pmed.0020097.t001
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report Unleashing Entrepreneurship: 
Making Business Work for the Poor 
[14] underscores the importance of 
partnerships with the private sector, 
especially the domestic private sectors 
in developing countries, in working to 
achieve the MDGs.
Perhaps most importantly, our 
results can provide guidance to the 
developing countries themselves to 
help target their growing initiatives in 
nanotechnology [15]. The goal is to 
use nanotechnology responsibly [16] to 
generate real beneﬁ  ts for the 5 billion 
people in the developing world.  
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